5-Aminolevulinic acid has the potential to prevent bladder dysfunction in cyclophosphamide-induced hemorrhagic cystitis.

Takahira KunoTakahiro ShimizuChiaki KawadaAtsushi KurabayashiSuo ZouHiroki MogawaMasayuki TsudaMotoaki SaitoKeiji Inoue

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

Pretreatment with 5-aminolevulinic acid expects protective effects on bladder dysfunction in cyclophosphamide-induced hemorrhagic cystitis by improving inflammatory changes in bladder tissues perhaps via up-regulation of haem oxygenase-1.

Keyphrases

spinal cord injury
oxidative stress
diabetic rats
photodynamic therapy
high glucose
low dose
high dose
gene expression
drug induced
urinary tract
risk assessment
endothelial cells
climate change